| 注册
首页|期刊导航|中国药房|药物目录遴选制度构建关键问题研究——基于典型国家遴选制度模式的经验

药物目录遴选制度构建关键问题研究——基于典型国家遴选制度模式的经验

李颖 王虎峰

中国药房2011,Vol.22Issue(24):2212-2214,3.
中国药房2011,Vol.22Issue(24):2212-2214,3.

药物目录遴选制度构建关键问题研究——基于典型国家遴选制度模式的经验

Key Issues of the Establishment of Drug List Selection System: Based on the Experience of Selection System Model in Typical Countries

李颖 1王虎峰2

作者信息

  • 1. 首都医科大学卫生管理与教育学院,北京市,100069
  • 2. 中国人民大学医改研究中心,北京市,100872
  • 折叠

摘要

Abstract

OBJECTIVE: To provide reference for the improvement of drug selection system in China.METHODS: Learning from the experiences of USA, UK and Germany, the definition of drug list selection system was confirmed; main factors for the establishment of drug selection system were summarized, i.e.professional selection decision making institution, main part, selection procedure.Based on general situation of drug list selection system in China, key issues of drug list selection system were interpreted respectively to put forward reasonable suggestion.RESULTS & CONCLUSION: It is the inevitable trend of the establishment of drug list selection system in China to set up professional selection decision making institution, allow stakeholders participation and standardize selection procedures.

关键词

药物目录/遴选决策/遴选机构/遴选程序/医改

Key words

Drug list/ Selection decision making/ Selection decision making institution/ Selection procedure/ Healthcare reform

分类

医药卫生

引用本文复制引用

李颖,王虎峰..药物目录遴选制度构建关键问题研究——基于典型国家遴选制度模式的经验[J].中国药房,2011,22(24):2212-2214,3.

中国药房

OACSCDCSTPCD

1001-0408

访问量3
|
下载量0
段落导航相关论文